Deloitte and Lucien Engelen sign partnership Collaboration.
Below the announcement from the website of Deloitte Center for the edge.
Deloitte and Lucien Engelen sign partnership Collaboration for Digital Health Strategy & Transformation to further reinforce its support to the healthcare market and in addition to that strengthen its impact as the worldwide number one on Digital Health, Deloitte proudly announces a collaboration with Lucien Engelen as Edge Fellow of the Deloitte Center for the Edge.
Lucien Engelen will support our team part-time as Global Strategist Digital Health with his experience, network and strategic thinking to increase the impact on health(care) by i.e. adapting the Digital DNA Framework into a version for healthcare. There is no question that in today’s digital age, the pace of disruption is only set to increase. As new technologies – such as the Internet of Things (IoT), artificial intelligence, robotics and virtual reality – proliferate, organizations are coming under mounting pressure to rethink not just their technology strategy but their entire operational strategy. The Digital DNA Framework helps organizations achieve their short- and long-term goals in the midst of this technological change, designed to guide the timely reconfiguration of the traditional operating model, allowing organizations to benefit from the new digital economy.
The Evolution of Digital Health(care)
Rapidly-evolving technologies and growing consumerism, along with demographic and economic changes, are expected to disrupt hospitals and other health(care) institutions worldwide. Already, a growing number of inpatient health care services are being pushed to the home and outpatient ambulatory facilities. However, many complex and very ill patients will continue to need acute inpatient services. With aging infrastructure in some countries and demand for more beds in others, hospital executives and governments should consider rethinking how to optimize inpatient and outpatient settings, how to best connect with consumers, and how to integrate digital technologies into traditional hospital services to truly create a health system without walls.
Traditional sectors are fading in the healthcare market and new parties are entering the playing field. But the challenge remains the same: how will the patient’s or care consumer’s world change and how will all those actors organize themselves in the (near) future? This transformation ignites one of the world’s biggest changes in the upcoming years. Deloitte wants to help to shape this change and whenever possible take responsibility for the results and help to accelerate progress and achievements. Being able to start this eminence collaboration with Lucien Engelen is another step forward in the ongoing development of our capabilities. Lucien Engelen will support the team part-time, one day a week.
About Lucien Engelen
Lucien Engelen (1962) is the founding director of the REshape Center for (healthcare) innovation (2010) and advisory to the executive board (2008) at Radboud University Medical Center in Nijmegen, The Netherlands. He is also core faculty at Singularity University’s Exponential Medicine in Silicon Valley (since 2011) and in the Netherlands (2016) and CEO of his own company called Transform.Health. He is a worldwide renown visionary expert in front-end health (care) innovation and a passionate and valued inspirational public speaker on the change of health(care). Lucien will continue his positions at Radboud university medical center.
About Center for the Edge
Deloitte Center for the Edge partners with senior executives to make sense of and profit from emerging opportunities on the edge of business and technology. We help leaders understand the fundamental changes shaping the world, navigate the short-term challenges and identify long-term opportunities. Center for the Edge, anchored in Silicon Valley with teams in Australia and Europe, conducts original research and develops substantive points of view, organizes exclusive sessions, and leverages an ecosystem of partners for new corporate growth.